Test your knowledge on chemotherapy for mTNBC

Combination chemotherapy is recommended for patients at risk for or in visceral crisis. True or false?

True

False

Which of the following regimens is recommended as a second-line therapy for patients with no germline BRCA mutation and no PD-L1 expression?

Pembrolizumab

Olaparib

Sacituzumab govitecan

Carboplatin

Which of the following regimens are recommended as a second-line therapy for patients with a known germline BRCA mutation and no PD-L1 expression?

Single-agent chemotherapy

Olaparib

Pembrolizumab

Single-agent chemotherapy and olaparib

Pembrolizumab combined with chemotherapy is approved for which patients?

PD-L1 with a CPS ≥5

PD-L1 with a CPS ≥10

PD-L1 negative

PD-L1 negative and no germline BRCA

{"name":"Test your knowledge on chemotherapy for mTNBC", "url":"https://www.poll-maker.com/QB8YUJQ9A","txt":"Combination chemotherapy is recommended for patients at risk for or in visceral crisis. True or false?, Which of the following regimens is recommended as a second-line therapy for patients with no germline BRCA mutation and no PD-L1 expression?, Which of the following regimens are recommended as a second-line therapy for patients with a known germline BRCA mutation and no PD-L1 expression?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}

Tools: Poll Maker | Quiz Maker | Super Surveys